cetuximab

常見例句

Purpose: Cetuximab is efficient in advanced colorectal cancer (CRC).
目的：西妥昔單抗對于晚期CRC有一定療效。
We previously showed that KRAS mutations were associated with resistance to cetuximab in 30 CRC patients.
我們之前研究顯示：KRAS突變與30個CRC患者對西妥昔單抗耐藥有關(guān)。
The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
法國及美國應(yīng)用西妥昔單抗治療直腸結(jié)腸癌最多，而芬蘭最低。
Cetuximab with chemotherapy as first-line treatment prolongs survival in head and neck cancers.
愛必妥與化療聯(lián)合作為頭頸部腫瘤的一線治療提高其生存（愛必妥，想要愛你不容易?。?/li>
The pharmacologic actions of cetuximab and its clinical evaluation are reviewed in this paper.
本文綜述了西妥昔單抗的藥理作用及臨床評價。
The largest disparities were in the use of the new colorectal and lung cancer drugs: bevacizumab, cetuximab, erlotinib and pemetrexed, the study found.
差別最為懸殊的是新型抗結(jié)腸直腸癌及肺癌藥物的應(yīng)用，這些藥物包括貝伐單抗、西妥昔單抗、埃羅替尼及培美曲塞。